Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | 0.00% | -0.81% | -9.56% |
09/05 | AVROBIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | North American Morning Briefing : Investors -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.56% | 55.18M | |
+4.95% | 109B | |
+10.91% | 105B | |
-0.38% | 22.25B | |
-12.27% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.07% | 16.85B | |
+4.61% | 13.76B | |
+34.76% | 12.46B |
- Stock Market
- Equities
- AVRO Stock
- News AVROBIO, Inc.
- AVROBIO to Sell Cystinosis Gene Therapy Program to Novartis for $87.5 Million